Literature DB >> 23020923

Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.

Z Atakan1, S Bhattacharyya, P Allen, R Martín-Santos, J A Crippa, S J Borgwardt, P Fusar-Poli, M Seal, H Sallis, D Stahl, A W Zuardi, K Rubia, P McGuire.   

Abstract

BACKGROUND: Cannabis can induce transient psychotic symptoms, but not all users experience these adverse effects. We compared the neural response to Δ9-tetrahydrocannabinol (THC) in healthy volunteers in whom the drug did or did not induce acute psychotic symptoms. Method In a double-blind, placebo-controlled, pseudorandomized design, 21 healthy men with minimal experience of cannabis were given either 10 mg THC or placebo, orally. Behavioural and functional magnetic resonance imaging measures were then recorded whilst they performed a go/no-go task.
RESULTS: The sample was subdivided on the basis of the Positive and Negative Syndrome Scale positive score following administration of THC into transiently psychotic (TP; n = 11) and non-psychotic (NP; n = 10) groups. During the THC condition, TP subjects made more frequent inhibition errors than the NP group and showed differential activation relative to the NP group in the left parahippocampal gyrus, the left and right middle temporal gyri and in the right cerebellum. In these regions, THC had opposite effects on activation relative to placebo in the two groups. The TP group also showed less activation than the NP group in the right middle temporal gyrus and cerebellum, independent of the effects of THC.
CONCLUSIONS: In this first demonstration of inter-subject variability in sensitivity to the psychotogenic effects of THC, we found that the presence of acute psychotic symptoms was associated with a differential effect of THC on activation in the ventral and medial temporal cortex and cerebellum, suggesting that these regions mediate the effects of the drug on psychotic symptoms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020923     DOI: 10.1017/S0033291712001924

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  15 in total

Review 1.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

2.  Impact of Cannabis Use on the Development of Psychotic Disorders.

Authors:  Samuel T Wilkinson; Rajiv Radhakrishnan; Deepak Cyril D'Souza
Journal:  Curr Addict Rep       Date:  2014-06-01

3.  Profiling the subjective effects of Δ⁹-tetrahydrocannabinol using visual analogue scales.

Authors:  Daniël Kleinloog; Frits Roozen; Willem De Winter; Jan Freijer; Joop Van Gerven
Journal:  Int J Methods Psychiatr Res       Date:  2014-02-05       Impact factor: 4.035

4.  Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis.

Authors:  J Cobb Scott; Samantha T Slomiak; Jason D Jones; Adon F G Rosen; Tyler M Moore; Ruben C Gur
Journal:  JAMA Psychiatry       Date:  2018-06-01       Impact factor: 21.596

5.  The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review.

Authors:  Maryam Sorkhou; Rachel H Bedder; Tony P George
Journal:  Front Psychiatry       Date:  2021-02-16       Impact factor: 4.157

Review 6.  Effects of cannabis on impulsivity: a systematic review of neuroimaging findings.

Authors:  Johannes Wrege; Andre Schmidt; Anna Walter; Renata Smieskova; Kerstin Bendfeldt; Ernst-Wilhelm Radue; Undine E Lang; Stefan Borgwardt
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.

Authors:  Else-Marie Løberg; Siri Helle; Merethe Nygård; Jan Øystein Berle; Rune A Kroken; Erik Johnsen
Journal:  Front Psychiatry       Date:  2014-11-18       Impact factor: 4.157

8.  Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects.

Authors:  André Schmidt; Felix Müller; Patrick C Dolder; Yasmin Schmid; Davide Zanchi; Matthias E Liechti; Stefan Borgwardt
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

Review 9.  Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.

Authors:  Rafael N Ruggiero; Matheus T Rossignoli; Jana B De Ross; Jaime E C Hallak; Joao P Leite; Lezio S Bueno-Junior
Journal:  Front Pharmacol       Date:  2017-06-21       Impact factor: 5.810

Review 10.  The Association between Cannabis Use, Mental Illness, and Suicidal Behavior: What is the Role of Hopelessness?

Authors:  Gianluca Serafini; Maurizio Pompili; Marco Innamorati; Elizabeth C Temple; Mario Amore; Stefan Borgwardt; Paolo Girardi
Journal:  Front Psychiatry       Date:  2013-10-11       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.